Overview

Phase I Study of Treatment for Persistent Infection With HPV-16

Status:
Not yet recruiting
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
Phase I clinical trial to assess drug safety and to find the maximum dose
Phase:
Phase 1
Details
Lead Sponsor:
PapiVax Biotech, Inc.
Collaborator:
University of Alabama at Birmingham